Skip to main content

Journals in Pharmaceutical sciences

Elsevier's Pharmaceutical Sciences collection helps pharmaceutical scientists striving to optimize drug design and improve healthcare outcomes by offering comprehensive coverage of every aspect of drug development, integrating disciplines like organic chemistry, biology, and biotechnology. Focused on safety, efficacy, and formulation design, it includes specialized fields such as Clinical Pharmacology and Translational Research, providing valuable insights into the latest advancements in drug discovery.

ASPET Discovery

  • ISSN: 3050-5674
This open access journal publishes a range of article types, including original research articles, minireviews, and viewpoints that address all areas of pharmacology and experimental therapeutics. These areas include, but are not limited to, topics on interactions of chemicals with biological systems; drug absorption, distribution, metabolism and disposition; drug delivery; mechanisms of drug actions; pharmacokinetics and pharmacodynamics; toxicology and adverse drug responses; behavioral pharmacology and drugs of abuse; and preclinical, translational, and clinical pharmacology. The journal will cover all types of therapeutic indications, such as cardiovascular, infectious, neurological, and cancerous; all forms of therapeutics, such as small molecules, biologics, and cells; and all research approaches, such as molecular, cellular, and systems pharmacology.

Acta Pharmaceutica Sinica B

  • ISSN: 2211-3835
  • 5 Year impact factor: 14.1
  • Impact factor: 14.7
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association Peer Review under the responsibility of Institute of Materia Medica, Chinese Academy of Medical Sciences and Chinese Pharmaceutical AssociationActa Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.APSB is a series of journal of Acta Pharmaceutica Sinica, which was founded in 1953, indexed in Chemical Abstracts, Index Medicus, SciFinder Scholar, Biological Abstracts, International Pharmaceutical Abstracts, Cambridge Scientific Abstracts, Current Bibliography on Science and Technology, etc. It sponsored by Insititute of Materia Medica, Chineses Acedemy of Medical Sciences and Chinese Pharmaceutical Association, production and hosting by Elsevier B.V.

Advanced Drug Delivery Reviews

  • ISSN: 0169-409X
  • 5 Year impact factor: 17.6
  • Impact factor: 15.2
The aim of the Journal is to provide a forum for the critical analysis of advanced drug and gene delivery systems and their applications in human and veterinary medicine. The Journal has a broad scope, covering the key issues for effective drug and gene delivery, from administration to site-specific delivery.In general, the Journal publishes review articles in a Theme Issue format. Each Theme Issue provides a comprehensive and critical examination of current and emerging research on the design and development of advanced drug and gene delivery systems and their application to experimental and clinical therapeutics. The goal is to illustrate the pivotal role of a multidisciplinary approach to modern drug delivery, encompassing the application of sound biological and physicochemical principles to the engineering of drug delivery systems to meet the therapeutic need at hand. Importantly the Editorial Team of ADDR asks that the authors effectively window the extensive volume of literature, pick the important contributions and explain their importance, produce a forward looking identification of the challenges facing the field and produce a Conclusions section with expert recommendations to address the issues.Articles review the current status of a specific topic, giving equal emphasis to the identification of major conceptual and technological challenges to successful drug and gene delivery, to an evaluation of triumphs as well as shortcomings in current conceptual and technical approaches, and to a discussion of their possible solution.Theme issues are commissioned by one of the Executive Editors or the Editor-in-Chief. The Journal does not publish stand alone manuscripts. If you wish to submit a theme issue topic for consideration, please contact one of the editors.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

American Journal of Pharmaceutical Education

  • ISSN: 0002-9459
  • 5 Year impact factor: 3.8
  • Impact factor: 3.8
The Official Journal of the American Association of Colleges of Pharmacy (AACP)The American Journal of Pharmaceutical Education is an official scholarly publication of the American Association of Colleges of Pharmacy (AACP). Its purpose is to document and advance pharmaceutical education in the United States and internationally.

Asian Journal of Pharmaceutical Sciences

  • ISSN: 1818-0876
  • 5 Year impact factor: 9
  • Impact factor: 10.7
Peer Review under responsibility of Shenyang Pharmaceutical UniversityAsian Journal of Pharmaceutical Sciences (AJPS) is the official journal of Asian Federation for Pharmaceutical Sciences (AFPS) and is indexed by Science Citation Index Expanded (SCIE). It provides the forum for reporting innovations, production methods, technologies, initiatives and the application of scientific knowledge to all aspects of pharmaceutics, including controlled drug release systems, drug targeting, physical pharmacy, pharmacodynamics, pharmacokinetics, pharmacogenomics, biopharmaceutics, drug and prodrug design, pharmaceutical analysis, drug stability, quality control, pharmaceutical engineering and material sciences.

Current Pharmaceutical Analysis

  • ISSN: 1573-4129
Current Pharmaceutical Analysis publishes full-length/mini reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis and pharmacological research. The journal is essential to all involved in pharmaceutical, biochemical, biomedicine and clinical analysis.This journal contains four sections:Section A (Pharmaceutical Science): This section focuses on the discovery, development, evaluation, and regulation of medications and therapies. Its main goal is to enhance human health by developing new pharmaceutical products, refining drug delivery methods, and ensuring both the safety and effectiveness of treatments.Section B (Toxicology and Pharmaceutics): This section focuses on the formulation, development, and toxicology response of drugs. It encompasses the design and testing of drug delivery systems to ensure optimal absorption, distribution, effectiveness and toxicity of medications in the body.Section C (Pharmaceutical Biotechnology): This section focuses on the utilizing biological systems, processes, or organisms to create drugs and treatments. It encompasses the development of biopharmaceuticals, including vaccines, monoclonal antibodies, gene therapies, and bionanotechnology. Additionally, it involves the application of bioengineering methods to alter cells and microorganisms for therapeutic applications.Section D (Drug Discovery): This section focuses on the identification, design, and development of new pharmaceutical compounds aimed at treating various diseases. It involves investigating novel chemical entities, natural substances, and biological molecules, utilizing methods such as high-throughput screening, molecular modeling, and structure-based drug design. The main goal is to discover safe, effective, and targeted treatments by comprehending disease mechanisms and refining lead compounds through preclinical evaluation.Editorial Board

Currents in Pharmacy Teaching and Learning

  • ISSN: 1877-1297
  • 5 Year impact factor: 1.7
  • Impact factor: 1.3
Currents in Pharmacy Teaching and Learning is devoted to dissemination of high quality, peer-reviewed scholarship relevant to all areas of pharmacy education—promoting educational research excellence. The Journal maintains a particular focus in two major areas: pharmacy faculty development in the scholarship of teaching and learning and the scholarship of interprofessional pharmacy education. With diverse editorial board members, authors, and peer reviewers, the Journal engages a variety of stakeholders in pharmacy education: educators, researchers, faculty practitioners, as well as interprofessional colleagues. Diverse author contributions are within original research, review articles, commentaries, and letters categories.Original research topics include, but are not limited to:Scholarship of Teaching and Learning: teaching/learning strategies; interprofessional educationQuality Improvement - assessment of programmatic/curricular outcomesCurricular Revision – design, implementation, evaluationNew school/program strategiesAttitudes/perceptions within pharmacy education

Drug Metabolism and Disposition

  • ISSN: 0090-9556
An important reference for all pharmacology and toxicology departments, DMD is also a valuable resource for medicinal chemists involved in drug design and biochemists with an interest in drug metabolism, expression of drug metabolizing enzymes, and regulation of drug metabolism enzyme gene expression. Articles provide experimental results from in vitro and in vivo systems that bring you significant and original information on metabolism and disposition of endogenous and exogenous compounds, including pharmacologic agents and environmental chemicals.

Drug Metabolism and Pharmacokinetics

  • ISSN: 1347-4367
  • 5 Year impact factor: 2.4
  • Impact factor: 2.7
Official Online Journal of the Japanese Society for the Study of Xenobiotics and the International Society for the Study of XenobioticsDrug Metabolism and Pharmacokinetics (DMPK) is an official online journal of the Japanese Society for the Study of Xenobiotics (JSSX) and the International Society for the Study of Xenobiotics (ISSX), and it replaces the JSSX's former journal, Xenobiotic Metabolism and Disposition. The journal will accept original submissions in English on the understanding that the work is unpublished and is not being considered for publication elsewhere.Scope of submitted manuscripts DMPK publishes original and innovative scientific papers that address topics broadly related to xenobiotics. The term xenobiotic includes medicinal as well as environmental and agricultural chemicals and macromolecules. The journal is organized into sections as follows: - Drug metabolism / Biotransformation - Pharmacokinetics and pharmacodynamics - Toxicokinetics and toxicodynamics - Drug-drug interaction / Drug-food interaction - Mechanism of drug absorption and disposition (including transporter) - Drug delivery system - Clinical pharmacy and pharmacology - Analytical method - Factors affecting drug metabolism and transport - Expression of genes for drug-metabolizing enzymes and transporters - Pharmacogenetics and pharmacogenomics - Pharmacoepidemiology

Drug Resistance Updates

  • ISSN: 1368-7646
  • 5 Year impact factor: 18.1
  • Impact factor: 15.8
Drug Resistance Updates publishes inspiring original research, commentary and expert reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology, and clinical medicine. The Editors welcome and encourage the submission of original research articles while review articles are written by leaders in the field of drug resistance by invitation.